- UroToday Home
- Urologic Oncology
Prostate Cancer Abstracts and Beyond
Recent Abstracts
-
MRI-based Radiomics for Predicting Prostate Cancer Grade Groups: A Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies.Prostate CancerJanuary 3, 2025
-
Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow-up analysis of the COVIDSurg-Cancer study.Prostate CancerJanuary 3, 2025
-
Prospective per-target analysis of the added value of the PrecisionPoint Transperineal Access System in cognitive prostate biopsy of MRI targets.Prostate CancerJanuary 3, 2025
-
Targeted microwave ablation of localised prostate cancer: Initial results of VIOLETTE trial.Prostate CancerJanuary 3, 2025
-
Infectious complications following transperineal prostate biopsy with or without periprocedural antibiotic prophylaxis-a systematic review including meta-analysis of all comparative studies.Prostate CancerJanuary 3, 2025
-
Challenges of Urologic Oncology in Low-to-Middle-Income CountriesProstate CancerJanuary 2, 2025
-
Urologic Cancer Drug Costs in Low- and Middle-Income CountriesProstate CancerJanuary 2, 2025
-
Life expectancy in rare histological prostate cancer subtypes.Prostate CancerJanuary 2, 2025
-
Prostate cancer MRI methodological radiomics score: a EuSoMII radiomics auditing group initiative.Prostate CancerJanuary 2, 2025
-
The PROCAN-B study protocol: Early diagnosis of PROstate CANcer for Black men-a community-centred participatory approach in Scotland and the North-East of England.Prostate CancerJanuary 2, 2025
Beyond the Abstracts
-
Risk Factors and Contemporary Management Options for Pain and Discomfort Experienced During a Prostate Biopsy - Beyond the AbstractProstate CancerJanuary 3, 2025
-
Multidimensional Healthcare Access Barriers to Prostate-Specific Antigen Testing: A Nation-Wide Panel Study in the United States From 2006 to 2020 - Beyond the AbstractProstate CancerJanuary 3, 2025
-
A PSA SNP Associates with Cellular Function and Clinical Outcome in Men with Prostate Cancer - Beyond the AbstractProstate CancerJanuary 2, 2025
-
Profiling of Urinary Extracellular Vesicle Protein Signatures from Patients with Cribriform and Intraductal Prostate Carcinoma in a Cross-Sectional Study - Beyond the AbstractProstate CancerJanuary 2, 2025
-
Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors - Beyond the AbstractProstate CancerDecember 19, 2024
-
Prostate-Specific Antigen at 3 Months as a Predictor of Radiologic Progression-Free Survival in Metastatic Hormone-Sensitive Prostate Cancer Treated with Apalutamide: Analysis of 633 Patients in a Real-World Database - Beyond the AbstractProstate CancerDecember 18, 2024
-
Oncologic Outcomes of Incidental Versus Biopsy-Diagnosed Grade Group 1 Prostate Cancer: A Multi-Institutional Study - Beyond the AbstractProstate CancerDecember 18, 2024
-
The Rapidly Evolving Treatment Landscape of Metastatic Hormone-Sensitive Prostate Cancer - Beyond the AbstractProstate CancerDecember 18, 2024
-
Adiposity and Muscle Strength in Men With Prostate Cancer and Cardiovascular Outcomes - Beyond the AbstractProstate CancerDecember 17, 2024
-
Comparison of Industry-Sponsored Trials (IST) and Investigator-Initiated Trials (IIT) in Advanced Genitourinary Cancers in the United States, Canada, United Kingdom, and France - Beyond the AbstractProstate CancerDecember 16, 2024